|
J Biol Chem, Vol. 273, Issue 16, 9510-9516, April 17, 1998
Circadian Periodicity of Intestinal Na+/Glucose
Cotransporter 1 mRNA Levels Is Transcriptionally Regulated*
David B.
Rhoads ,
David H.
Rosenbaum,
Hilal
Unsal,
Kurt J.
Isselbacher, and
Lynne L.
Levitsky
From the Pediatric Endocrine Unit, Massachusetts General Hospital,
Laboratory of Tumor Biology, Massachusetts General Hospital Cancer
Center and Departments of Medicine and Pediatrics, Harvard Medical
School, Boston, Massachusetts 02114
 |
ABSTRACT |
Intestinal expression of the high affinity
Na+/glucose cotransporter 1 (SGLT1), which absorbs
dietary glucose and galactose, exhibits both circadian periodicity in
its activity and induction by dietary carbohydrate. Because the daily
variation in SGLT1 activity is established by the feeding schedule
(whether ad libitum or imposed) and persists in the absence
of food, this variation has been described as anticipatory. To
delineate the mechanisms regulating SGLT1, its expression was examined
in rats maintained in a 12-h photoperiod with free access to chow.
SGLT1 mRNA levels varied significantly, with the maximum abundance
occurring near the onset of dark and the minimum near the onset of
light. The SGLT1 transcription rate was 7-fold higher in the morning
(1000-1100 h) than in the afternoon (1600-1700 h). An element for
hepatocyte nuclear factor 1 (HNF-1) was identified in the SGLT1
promoter that formed different complexes with small intestinal nuclear extracts, depending on the time when the source animal was killed. Serological tests indicated that HNF-1 was present in complexes throughout the day, while HNF-1 binding exhibited circadian
periodicity. We propose that exchange of HNF-1 dimerization partners
contributes to circadian changes in SGLT1 transcription. Because SGLT1
mRNA levels also varied in rhesus monkeys (offset by approximately one-half day from rats), a similar mechanism appears to be present in
primates.
 |
INTRODUCTION |
The central role of glucose in cellular metabolism has led to the
evolution of two gene families of eukaryotic glucose transporters, each
with a specific cell and tissue expression pattern to subserve its
particular functions (for review, see Hediger and Rhoads (1)). Na+/coupled glucose transporters
(SGLTs),1 which couple
glucose uptake to the inwardly directed electrochemical Na+
gradient (2), are expressed at the luminal brush-border (apical) surface to absorb glucose. Facilitated glucose transporters (GLUTs), which permit passive movement of glucose across plasma membranes down
its concentration gradient, are generally expressed on serosal (basolateral) surfaces to release absorbed glucose into the
bloodstream. Identification of several glucose transporters by cDNA
cloning over the last several years has permitted characterization of the expression pattern and regulatory behavior of the individual glucose transporters. The high affinity SGLT1 is expressed in the
apical membranes of the renal proximal tubule and the intestinal mucosa
to (re)absorb glucose, which is released into the bloodstream via
basolaterally expressed GLUT2- and GLUT1-facilitated glucose transporters (3-6). The intestine also expresses GLUT5 (7), a
facilitated fructose transporter localized to the brush-border membrane
(4).
Intestinal glucose transporter expression in rodents exhibits circadian
periodicity, induction by carbohydrate intake, and dysregulation in
experimental diabetes. Glucose uptake activity in rats fed ad
libitum peaks late in the dark phase (8) or early in the light
phase (9) and depends on the imposed feeding schedule rather than the
light cycle (8, 10). Because the food consumption pattern in rats fed
ad libitum is established by the light cycle (11), the
circadian rhythmicity of glucose transport activity is "cued by
feeding" (10) rather than the result of an inherent oscillatory
behavior of the small intestine. Persistence of this periodicity in
animals deprived of food has led to concept that this behavior is
anticipatory, i.e. dependent on prior rather than current
food intake (12). The recent demonstration of diurnal periodicities in
the mRNA levels of SGLT1, GLUT2, and GLUT5 (13) suggests that
transcriptional changes may underlie this anticipation, but this
hypothesis is as yet untested.
Responsiveness of intestinal glucose transporter expression to
carbohydrate intake has been explored by Ferraris et al.
(14-17). These authors reported that long term adaptation of mice to a high carbohydrate diet resulted in significantly more intestinal glucose transporters as assayed by the binding of phloridzin (a specific inhibitor of Na+/glucose cotransporters) (14).
Moreover, from the kinetics of change in phloridzin binding along the
crypt-villus axis in response to shifting from a no carbohydrate to a
high carbohydrate diet (or vice versa), these authors proposed that
enterocytes can alter glucose transporter expression only in response
to carbohydrate availability as they exit the crypt (15, 17). However,
whether changes occurred at the transcriptional or posttranscriptional level was not addressed. Moreover, the modulation of SGLT1 expression in the absence of dietary shifts was not examined. In rats, a shift
from a no carbohydrate to a high carbohydrate diet resulted in
increased SGLT1 transcription over a 5-day period (18), but only one
time point per day was examined.
Finally, the up-regulation of the glucose transporter expression in
streptozotocin-induced diabetic rats (19) appears to be due to a
premature induction of SGLT1 mRNA and protein along the
crypt-villus axis (20). However, the molecular mechanism(s) underlying
this induction are not known.
To elucidate the mechanisms underlying SGLT1 regulation, we began by
examining the influence of nutritional status (dietary carbohydrate
content and fasting-refeeding) on intestinal SGLT1 mRNA levels.
Remarkably, a distinct circadian rhythmicity in SGLT1 mRNA levels
and transcription were observed in the absence of dietary manipulation.
These findings place a specific interpretation on the anticipatory
expression of digestive functions (12). Furthermore, these data suggest
that dietary influences regulating the SGLT1 gene and its
pathological dysregulation are more complex than previously
appreciated.
 |
EXPERIMENTAL PROCEDURES |
Chemicals--
32P-Labeled nucleotides were obtained
from NEN Life Science Products. Antiserum recognizing all three rat
C/EBP isoforms was obtained from Santa Cruz Biotechnology (Santa Cruz,
CA). All other chemicals were of the highest purity commercially
available.
Animals--
Rats were maintained in accordance with the NIH
Guide for the Care and Use of Laboratory Animals and were
housed in wire-bottomed cages within an AAALAC-accredited animal
facility under an approved research protocol. The room was maintained
at 21-22 °C with a 12-h photoperiod (0700-1900 h). Six-week-old
female Sprague-Dawley rats (Taconic Farms, Taconic, NY) were
adapted to the animal facility for at least 5 days prior to the
initiation of any study. Animals were allowed ad libitum
access to water and standard laboratory chow (Rodent Laboratory Chow,
Purina 5001) throughout each study.
Duodenal biopsies were obtained from three young adult female rhesus
monkeys housed at the New England Regional Primate Research Center
(Southborough, MA) under a protocol approved by Harvard Medical Area
Standing Committee on Animals. Monkeys were fasted for 12 h prior
to biopsy under light general anesthesia (Telazol, 7.5 mg/kg). Five to
six biopsies were immediately frozen in liquid nitrogen and later
combined for extraction of RNA (see below).
Nucleic Acid Probes--
The following cDNA probes were used
for Northern blot and transcription rate analyses: rat SGLT1 (21),
human SGLT1 (22), rat GLUT2 (23), rat GLUT5 (24), rat
sucrase-isomaltase (25), rat liver-type pyruvate kinase (26), human
c-myc (provided by E. Schmidt, Massachusetts General
Hospital, Boston, MA), and rat -tubulin (provided by A. Rustgi,
Massachusetts General Hospital). Probes were radiolabeled with
[ -32P]dCTP using MegaPrime (Amersham Corp.). For
nuclear run-on transcription assay, plasmids were linearized and
immobilized on Hybond-N membrane. pBSK( ) (Stratagene, La Jolla, CA)
was used as a negative control. For genomic cloning, a 127-nt
BstXI fragment from the rat SGLT1 cDNA
(GenBankTM accession no. U03120) was labeled with
[ -32P]dCTP using MegaPrime and a synthetic nonamer
complementary to the 3'-terminus of the upper strand instead of the
random primers included in the kit.
Northern Blot Analysis--
Under anesthesia, jejunums were
removed, flushed with cold phosphate-buffered saline, and everted, and
the mucosa was scraped. One portion of mucosa was rapidly frozen in
liquid nitrogen for later extraction of RNA (27), while the other was
used to prepare postnuclear membranes (see below). Equal amounts (20 µg) of RNA were loaded per lane on 1% formaldehyde-agarose gels.
After electrophoresis, the RNA integrity was confirmed by ethidium
bromide staining, and the RNA was transferred to Hybond-N filters
(Amersham Corp.). Following hybridization in Rapid-Hybe buffer
(Amersham Corp.), blots were washed three times in 2× SSC, 0.1% SDS
(1× SSC is 0.15 M NaCl, 15 mM sodium citrate,
pH 7.0) for 10 min at room temperature, once in 1× SSC, 0.1% SDS for
15 min at 65 °C, three times in 0.1× SSC, 0.1% SDS for 20 min at
65 °C, and exposed on Kodak XAR-5 film at 80 °C with double
intensifying screens. To detect different mRNAs, probes were
stripped from filters by boiling in 0.1% SDS. Filters were
successfully probed four times without loss of sensitivity. Densitometry was performed using NIH Image software.
Western Blot Analysis--
Postnuclear membranes were prepared
from isolated intestinal mucosal cells (see below) according to the
method described by Burant et al. (20). Equal amounts of
membrane protein (10 µg) as estimated by the Bradford method
(Bio-Rad) were resolved by SDS-polyacrylamide gel electrophoresis (12%
gel), and electrophoretically transferred to PVDF-Plus membrane filter
(Micron Separations Inc., Westboro, MA). SGLT1 protein was detected
using a 1:7000 dilution of antiserum raised against the rabbit SGLT1
peptide sequence (amino acids 604-615) (28) and the Western
LightTM chemiluminescence detection kit (Tropix, Bedford,
MA).
Preparation of Nuclei from Isolated Intestinal Mucosal Cells and
Transcription Rate Assay--
Mucosal cells were isolated from
intestinal villi at 4 °C (29). The three villus tip fractions
(V1, V2, and V3) following the
first wash (Vw) were combined and recovered by
centrifugation for 5 min at 500 × g. Cells were lysed
on ice in 15 ml of lysis buffer (Tris-Cl, 10 mM, pH 7.4, 3 mM MgCl2, 10 mM NaCl, 0.5 mM dithiothreitol, and 0.5% Nonidet P-40) with 10 gentle
strokes in a Dounce homogenizer using the loose (B) pestle. Nuclei were
recovered by centrifugation for 10 min at 500 × g,
carefully suspended in 1 volume of storage buffer (Tris-Cl, 50 mM, pH 8.3, 5 mM MgCl2, 40%
glycerol, and 0.1 mM EDTA), and stored at 80 °C in
200-µl aliquots. Transcription rate assays were performed by a
modification of the method of Greenberg (30). Following quantitation of
incorporation, an equal number of disintegrations/min from each sample
were precipitated for 30 min with 0.4 M LiCl and 2 volumes
of ethanol at 80 °C, then recovered by centrifugation at
12,000 × g for 30 min at 4 °C. The RNA samples were
dissolved in 1.0 ml of Rapid-Hybe buffer, transferred to siliconized
glass scintillation vials containing the filter-bound plasmids (5 µg
each), and hybridized for 20 h at 65 °C. Following washing, the
filters were exposed to ReflectionTM film (NEN Life Science
Products).
Preparation of Nuclear Extracts--
Extracts were prepared from
isolated small intestinal epithelial cell nuclei by a modification of
the method of Dignam et al. (31). Extraction was performed
with 2 volumes of buffer C (25 mM Na-Hepes, pH 7.4, 0.4 M NaCl, 0.2 mM EDTA, 0.5 mM
dithiothreitol) containing 0.4 mM phenylmethylsulfonyl
fluoride and 0.5 µg/ml each aprotinin, leupeptin, and antipain.
Debris was removed by centrifugation at 11,000 × g for
15 min, dialyzed against buffer D (20 mM Na-Hepes, pH 7.9, 0.1 M KCl, 0.2 mM EDTA, 0.5 mM
dithiothreitol, and 20% glycerol) for 3-4 h, and centrifuged again
prior to storage at 80 °C.
Genomic Cloning--
A rat genomic library (500,000 plaques; CLONTECH, Palo Alto, CA) was
screened with the SGLT1 BstXI fragment using protocols provided by the supplier. Of approximately 20 positive clones identified, sequence analysis (Sequenase, U. S. Biochemical Corp., Cleveland, OH) indicated that clone -H2 contained a 17-kb insert that included Exon 1.
Electrophoretic Mobility Shift Assays (EMSA)--
EMSAs were
performed using a modification of the method of Bernards (32). Briefly,
binding reactions with 10 µg of protein, 125 ng of salmon testis DNA
(Sigma), and 10,000 cpm double-stranded oligonucleotide probe were
prepared on ice, incubated at room temperature for 15 min, and
electrophoresed for 45 min in a 4% polyacrylamide gel at 4 °C in a
MiniProtean II gel electrophoresis apparatus (Bio-Rad). Binding buffer
consisted of Na-Hepes, pH 7.4, 100 mM KCl, 5 mM
MgCl2, 0.5 mM EDTA, 1 mM
dithiothreitol, and 5% glycerol. Electrophoresis buffer was 0.5× TBE
(1× TBE is 89 mM Tris, 89 mM boric acid, pH
8.3, and 2 mM EDTA). The probe was prepared by annealing
complementary synthetic oligonucleotides, 32P-end-labeled
with T4 polynucleotide kinase (New England Biolabs, Beverly, MA), and
purified by nondenaturing polyacrylamide gel electrophoresis. Antisera
to HNF-1 isoforms and were provided by Dr. G. R. Crabtree
(33), and 0.5 µl was added to each indicated binding reaction.
 |
RESULTS |
To examine the regulation of the SGLT1 gene, we
initially tested two protocols to assess the influence of dietary
carbohydrate on intestinal SGLT1 mRNA abundance: varying the
carbohydrate content in the chow and fasting/refeeding. While both
interventions altered mRNA levels, temporal changes in mRNA
abundance in control animals were clearly greater than those induced by
experimental manipulations. Furthermore, these changes were
reproducible from day to day, following a circadian periodicity. To
examine the basis for the rhythmicity in SGLT1 mRNA levels
occurring in animals maintained under standard conditions (12-h
photoperiod with free access to food and water), we conducted the
experiments described below. For rats, both activity and food
consumption are greater during the night than the day. Thus, the
observed changes in SGLT1 expression are likely in response to the
feeding pattern established by the photoperiod and not intrinsic clock
signals per se.
Intestinal SGLT1 Expression in the Rat Varies in a Circadian Manner
at Both the mRNA and Protein Levels--
To follow the abundance
of intestinal SGLT1 mRNA over the course of a day, Northern blots
were prepared from RNA extracted from jejunal mucosal scrapings of rats
killed at 6-h intervals. In a typical experiment (Fig.
1A), significantly more SGLT1
mRNA was present in the jejunal mucosa of rats killed at 1600 and
2200 h than those killed at the other times. In six sets of
animals examined (age range, 7-9 weeks), densitometry indicated that
the level at 2200 h was 3.7 ± 0.1 times (p < 0.001) greater than at 0400 h (Fig. 1C).
Sucrase-isomaltase and liver-type pyruvate kinase (L-PK)
showed similar circadian variations (Fig. 1A). In another experiment in which rats were sacrificed at 3-h intervals around the
beginning of the dark phase, the peak SGLT1 mRNA level occurred at
1900 h, the time of lights out (not shown).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 1.
Daily variation in intestinal SGLT1
expression. Northern and Western blot analysis of small intestinal
mucosal cells. See "Experimental Procedures" for details.
A, Northern blot analysis. Female Sprague-Dawley rats were
killed at the indicated times, and their jejunal mucosa were scraped
for preparation of RNA. Total jejunal RNA (20 µg/lane) was
sequentially hybridized with 32P-labeled cDNA probes
for SGLT1, sucrase, liver-type pyruvate kinase (L-PK),
c-myc, and -tubulin ( -Tub). B,
Western blot analysis. Female Sprague-Dawley rats were killed at the
indicated times and postnuclear membranes were prepared from isolated
villus mucosal cells. Membrane proteins (10 µg/lane) were probed with
rabbit polyclonal antibodies against SGLT1. C densitometric
analysis of rat jejunal SGLT1 mRNA and protein levels. Film
intensity signals of SGLT1 mRNA (n = 6 per time
point) and protein (n = 4 per time point) from rats
killed at 6-h intervals were quantitated by scanning densitometry and
indexed to the respective intensity obtained at 0400 h. *p < 0.02 versus 0400 h; **p < 0.001 versus 0400 h (log-transformed data). Error
bars for SGLT1 protein at 1000 and 2200 h fell within the
column borders. D SGLT1 mRNA levels in a young adult
female rhesus monkey. Duodenal biopsies were obtained from the same
monkey at 0900 h (AM) and 2000 h (PM) 2 weeks apart. Total RNA (5 µg) was hybridized with a
32P-labeled cDNA for human SGLT1.
|
|
Western blotting revealed that SGLT1 protein levels were higher at both
1600 and 2200 h, consistent with the increased mRNA levels at
those times. (Fig. 1, B and C). Thus, the
increased transporter activity observed by other investigators (8, 9) appears to be due to increased SGLT1 protein synthesis from the increased mRNA levels.
The intestinal expression as determined by Northern blotting of several
other carbohydrate responsive genes, GLUT2,
GLUT5, and lactase-phloridzin hydrolase, exhibited similar
behavior (not shown). These genes also varied in the ileum, but to a
lesser extent. The mRNA levels of glyceraldehyde phosphate
dehydrogenase (not shown), as well as that for -tubulin (Fig.
1A), were constant. Also shown is that the mRNA level
for c-myc, a marker of cell proliferation, does not change
in intestinal mucosal cells over the course of the day (Fig.
1A).
Monkeys also Exhibit Circadian Variation in SGLT1 mRNA
Levels--
To determine whether the SGLT1 mRNA level also changes
in primates, RNA was extracted from duodenal biopsies of rhesus monkeys obtained at either 0900 or 2000 h (taken 2 weeks apart). In the analysis of the monkey shown, the SGLT1 mRNA level was over 5-fold higher in the morning than in the evening (Fig. 1D). Monkeys
express two SGLT1 mRNA species, probably corresponding to the 4.8- and 2.6-kb species found in humans (22). Two additional monkeys exhibited identical behavior (densitometric differences were 5.5-, 4.7-, and 6.1-fold higher in the morning for the three monkeys). Thus,
a daily rhythmicity of SGLT1 mRNA levels appears to be a general
phenomenon, with its occurrence in the diurnal primate shifted
approximately half a day from that found in the nocturnal rat.
SGLT1 Transcription Varies in a Circadian Manner--
To assess
the involvement of transcription in the SGLT1 mRNA periodicity,
nuclei were isolated from rat jejunal mucosal cells for a transcription
rate assay. Cells can be sequentially eluted from the intestinal mucosa
along the villus-crypt axis by incubating the intestine in buffer
containing a chelating agent to remove divalent cations (34). To
optimize preservation of transcriptional activity of nuclei during
isolation, a low temperature modification employing citrate as the
chelator in place of EDTA was used (29). In nuclei isolated from
combined villus tip enterocytes prepared by this method, SGLT1
transcription was several times higher in nuclei from enterocytes
obtained at 1100 versus 1630 h (Fig.
2A). As expected, the
-tubulin signal was similar at both times. In four experiments, the
SGLT1 signal estimated densitometrically (normalized to the -tubulin
signal) was 6.4 ± 1.0 times greater between 1000 and 1100 h
than between 1600 and 1700 h (p < 0.007, 2-tailed
t test). A GLUT2 signal was not detected at either time examined while that of GLUT5 appeared similar at both times (Fig. 2A). These data indicate that the SGLT1 transcription rate
is not constant, but also exhibits periodicity. In a study in which nuclei were isolated at 6-h intervals, the marked increase in SGLT1
transcription was observed only at 1000 h, but not at the other
times examined (Fig. 2B). A modest signal was also detected for Sucrase and GLUT2 at 1000 h, but not at the other times. The rates of transcription of glyceraldehyde-3-phosphate dehydrogenase and
-tubulin were constant.

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 2.
SGLT1 transcription rate varies during the
day. Villus tip enterocytes were eluted from jejunums of
7-week-old female Sprague-Dawley rats beginning at the indicated times,
followed by isolation of nuclei. See "Experimental Procedures" for
details. For the transcription rate assay, equal amounts of
radiolabeled RNA (5 × 105 cpm) derived from 100 µl
of packed nuclei were hybridized to the indicated linearized plasmids
cross-linked to Hybond N membranes. The washed membranes were exposed
to NEN Reflection film. A, comparison of transcription at
1100 h versus 1630 h. B, comparison of
transcription at 6-h intervals.
|
|
Cloning the Rat SGLT1 Gene Promoter--
The temporal change in
the SGLT1 transcription rate suggested that the SGLT1
promoter contains one or more elements responsible for its periodic
activity. To obtain information on the rat SGLT1 promoter, a
genomic library was probed with a 5'-terminal BstXI restriction fragment from the rat cDNA (21). One of the positive clones contained a 6-kb BamHI fragment that included the
first exon and approximately 1 kb of 5'-flanking sequence of the rat SGLT1 gene. A restriction map of the upstream 2.3 kb of this
fragment and the sequence of the first 971 nt are shown in Fig.
3. The first exon-intron boundary occurs
within the same codon as in humans (35). The 300 nt upstream of the
TATA box show 70% identity to the same region in the human gene (35).
The putative mRNA start site (by homology to the human sequence) is
30 base pairs downstream of the TATA box. The reported sequence of the
rat SGLT1 cDNA clone (21) contained 69 bp upstream of the TATA box
(nt 867 in Fig. 3B). It is not clear whether these
additional nucleotides arose from a cryptic upstream start site or were
merely part of an aberrant transcript. Analysis of the sequence for
transcription factor binding sites (Wisconsin Package, Genetics
Computer Group, Madison, WI) using the Tfdsites data base (36) revealed
the presence of potential sites for MLTF/USF (major late transcription factor/upstream stimulatory factor) and HNF-1 (hepatocyte nuclear factor 1) (Fig. 3B). Of note, the presence of the HNF-1 and
the MLTF/USF sites is reminiscent of the carbohydrate response element found in liver-type pyruvate kinase, which in addition to these two
sites also contains closely linked sites for NF1 and HNF-4 (37). These
latter two sites may be responsible for the largely liver expression of
this gene. However, liver type pyruvate kinase is also expressed as a
minor pyruvate kinase isoform in the small intestine, but it shows a
similar diet responsiveness in both tissues (38).

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 3.
Proximal promoter region of the rat
SGLT1 gene. Top, restriction map of a 2.3-kb
fragment derived from -phage clone H2. The fragment shown contains
the TATA box and the first exon. Numbers beneath restriction sites are
nucleotide distances from the putative transcription start site.
Bottom, nucleotide sequence of the SGLT1 proximal promoter,
ending at the nucleotide immediately before the putative transcription
start site, homologous to the human transcription start site (35). The
arrow indicates the first nucleotide of the rat SGLT1
cDNA (21). Potential binding sites for MLTF/USF and HNF1
transcription factors are underlined. The
GenBankTM accession no. of the sequence is AF007832.
|
|
Nuclear Factor Binding to the SGLT1 Promoter Exhibits Circadian
Periodicity--
The observed circadian changes in SGLT1 transcription
suggest the presence of concomitant circadian changes in the abundance or activity of transcription factor(s). Because the carbohydrate response element in the liver type pyruvate kinase gene is important in
its regulation, we reasoned that the analogous region in the SGLT1 gene
might account for its circadian periodicity. In preliminary experiments, EMSAs using a 53-bp probe containing both the MLTF/USF and
the HNF-1 binding sites (Fig. 3B; nt 878-930), two
different complexes were formed depending on the time intestinal
mucosal cells were isolated as sources of nuclear extracts (not shown). Competition assays with a series of overlapping 21-mers indicated that
the 3'-terminus (Fig. 3B; nt 910-930), which included the putative HNF-1 element, contained the element(s) able to form the two
different complexes (not shown). Further experiments were performed
with the 21-bp probe containing the HNF-1 site, referred to as the HNF
probe. When the HNF probe was end-labeled, temporally dependent binding
was also observed, a more rapidly migrating AM complex at
1000 h and again at 0400 h and a slower and broader PM
complex at 1600 and 2200 h (Fig.
4A, left).
Inclusion of a 500-fold excess of unlabeled competitor reduced the
signal obtained for either complex to below detectable levels (Fig.
4A, right).

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 4.
Periodicity in SGLT1 DNA-protein complex
migration. EMSAs were performed using extracts prepared from
intestinal mucosal cell nuclei isolated at 6-h intervals. See
"Experimental Procedures" for details. A,
left, binding reactions showing the temporal occurrence of
the AM and PM complexes formed with the SGLT1 HNF
probe. Right, binding reactions containing a 500-fold excess
of unlabeled probe DNA. B, EMSAs were performed with 0.5 µl of antiserum to HNF-1 preincubated with nuclear extracts for 45 min on ice prior to addition of the labeled SGLT1 HNF probe to initiate
complex formation. C, EMSAs were performed with the SGLT1
HNF probe, and 0.5 µl of antiserum to HNF-1 was added prior to
loading on the gel.
|
|
To determine whether HNF-1 isoforms were involved in either the AM or
the PM complex, the effect of antisera to the and isoforms of
HNF-1 (33) were examined in EMSAs. When antiserum to HNF-1 was
included in the binding reaction, the PM complex was absent and a new
complex co-migrating with the AM complex appeared (Fig. 4B).
Thus, the AM and the PM complexes differed both in gel migration and in
sensitivity to HNF-1 antiserum. Addition of antiserum to HNF-1 to
the binding reaction immediately prior to electrophoresis did not
affect migration of either complex (data not shown). This behavior
suggests that the HNF-1 antiserum prevents the binding of
HNF-1 .
On the other hand, when antiserum to HNF-1 was added to the binding
reactions, two supershifted complexes could be observed in both the AM
and PM complexes (Fig. 4C). A probe derived from the rat
albumin HNF1 site (39) formed similar DNA-protein complexes with
intestinal mucosal nuclear extracts, and an unlabeled albumin HNF probe
competed with the SGLT1 HNF probe and vice versa (not shown). Thus,
HNF-1 appears to be present in both the AM and PM complexes, while
HNF-1 is present in at least the PM complex. The presence of
HNF-1 in the AM complex cannot be unambiguously established at this
time. Although the HNF probe also overlaps with a potential C/EBP
binding site, an antiserum directed against all three isoforms of rat
C/EBP failed to affect the migration of either the AM or the PM complex
(not shown).
 |
DISCUSSION |
A daily periodicity in the intestinal transport activity and
several other digestive proteins were documented before the genes responsible were characterized at the molecular level. Nevertheless, the observed activity changes were clearly ascribed to the feeding pattern (whether ad libitum or scheduled) rather than to an
inherent circadian signal. However, the specific mechanisms linking
food intake to gene expression remained obscure. The cloning of
cDNAs from various diet-responsive genes has now provided the
opportunity to explore their molecular regulation. Using the rat SGLT1
cDNA as a probe, we have detected a periodicity in intestinal SGLT1 expression, both at the level of mRNA abundance and transcriptional activity. Moreover, analysis of the 5'-flanking region of the rat
SGLT1 gene has revealed an HNF-1 element capable of forming different complexes with nuclear extracts depending on the time of day
intestinal mucosal cells were isolated. These studies provide evidence
for a periodicity in HNF-1 activity, possibly occurring via exchanges
in dimerization partners.
The Timing of SGLT1 Transcription--
The marked changes in SGLT1
mRNA levels over a 24-h period likely results from modulations in
both net mRNA synthesis and degradation. To understand the
mechanisms underlying these changes, we initially focused on
transcription. When transcription was examined in nuclei isolated at
either 1100 and 1630 h, points near the lowest mRNA abundance
and the midpoint of the mRNA increase, respectively, it was found
that the SGLT1 transcription rate at the earlier time was 7-fold higher
than at the later time. This observation raises two points. First, for
nocturnal rats, transcription is high and mRNA levels increase
during their inactive period in the light. Thus, the cue(s) to increase
SGLT1 transcription must lie either in (i) a specific stage of the
digestive process of the previous night's meal or (ii) a more global
habituation pattern. While the present data do not distinguish between
these two possibilities, it remains clear that anticipatory expression of SGLT1 includes induction of SGLT1 gene transcription. Second, because mRNA levels are still increasing when SGLT1 transcription rate subsides in the afternoon, it is likely that there is a
concomitant increase in mRNA stability. Likewise, the precipitous
drop of mRNA levels during the night may be due to an increase in
the mRNA degradation rate. This hypothesis remains to be tested
directly.
Role of the HNF-1 Promoter Element--
Isolation of the rat
SGLT1 promoter region has permitted the identification of an
HNF-1 binding site immediately upstream of the TATA box. HNF-1 proteins
are a group of atypical homeodomain proteins (40) expressed in liver,
kidney, and gut involved in the tissue-specific expression of several
genes in these tissues (39). To date, (33) and (41) isoforms
have been described, having similar target binding sequences but
differing in relative abundance in expressing tissues. HNF-1 proteins
form both homo- and heterodimers, with dimerization stabilized and
transcriptional activity enhanced by the further binding of a dimer of
a third partner named DCoH (for dimerization
cofactor of HNF-1) (42). In the present study,
we have found that the change in the SGLT1 transcription rate is
accompanied by a change in the HNF-1 isoform complement at the HNF-1
site as detected by gel-shift assays. Specifically, early in the light
phase when transcription is high (1000-1100 h), nuclear extracts form
the AM complex with the HNF-1 probe containing HNF-1 . Later in the
light phase when transcription is lower (1600-1630 h), the PM complex
forms containing both HNF-1 and HNF-1 . Thus, it is tempting to
speculate that SGLT1 transcription is in part regulated by the
DCoH-mediated exchange of an HNF-1 for an HNF-1 partner during
transcriptional activation. Further studies will be necessary to
establish the composition of the HNF-1 dimers unambiguously as well as
to determine the involvement of DCoH.
It is instructive to compare the HNF-1 site identified in the
SGLT1 gene to HNF-1 sites in related genes (Scheme 1).
First, the rat SGLT1 sequence shows an 11/13 match to the consensus
HNF-1 target sequence (39). Moreover, the 13 nucleotides are identical between the rat and human and occur in the same position in relation to
the TATA boxes. Also of note, the expression of two other
carbohydrate-responsive genes, sucrase-isomaltase (43) and liver type
pyruvate kinase (including its expression in the small intestine (38),
are dependent on HNF-1. The HNF-1 elements in these two genes show 9/13
and 8/13 identity to the rat SGLT1 element, respectively. In
particular, the terminal 5 nt, "TTAAC," are present in all four
genes. It will be interesting to examine the nature of the HNF-1
complexes formed using these two sequence elements as probes. Finally,
similar HNF-1 binding sequences are not present in the proximal
promoter regions of either GLUT2 (44) or GLUT5
(45). The lack of consensus HNF-1 elements in these two genes suggests
that other mechanisms may operate to induce circadian rhythmicity of
GLUT2 and GLUT5 mRNA levels.
We found no evidence for the involvement of C/EBP, a factor which
cooperates with the D-box-binding protein to set the diurnal liver
expression pattern of CYP7 (46).
Model of Intestinal SGLT1 Regulation--
Our data suggest that
changes in both transcription and mRNA stability contribute to the
anticipatory expression of intestinal digestive functions (47). We
hypothesize that both processes regulate SGLT1 (as well as perhaps
liver type pyruvate kinase and sucrase-isomaltase) as follows. (i) At
the beginning of the rest phase as the stomach empties, a burst of
SGLT1 transcription initiates mRNA accumulation; (ii) as
transcription slows, mRNA stabilization permits further
accumulation; (iii) synthesis and membrane insertion of new
transporters lead to peak activity later in the morning; (iv) when
feeding ensues in the evening, mRNA destabilization leads to its
loss during the night; and (v) SGLT1 activity decreases to its base
line by protein turnover and enterocyte sloughing.
The circadian rhythmicity in SGLT1 expression documented here
underscores the complexities underlying regulation of this gene. Moreover, it is clear that any study comparing different physiological states needs to include a series of sample times to confirm that differences noted are not due to shifts in the temporal occurrence of
mRNA peak levels or transcriptional bursts. The similar periodicity present in rhesus monkeys demonstrates its generality and suggests that
SGLT1 periodicity also occurs in humans.
HNF-1 is a developmentally regulated transcription factor responsible
for the tissue-specific expression of several genes (39). While the
place of HNF-1 in the induction of these genes during organogenesis and
their continued expression in postnatal life is well established, a
role for HNF-1 in the on-going postnatal regulation of target genes has
not been described. Our results suggest that diurnal HNF-1 binding
is a mechanism that mediates the habituation to environmental cues,
literally a temporal pattern formation beyond its role in
morphogenesis. Finally, the recent determination that mutations in
HNF-1 lead to type 3 maturity-onset diabetes of the young (48)
provides impetus to understand the mechanisms by which this
homeoprotein interacts with its target genes.
 |
ACKNOWLEDGEMENT |
We are grateful to K. Kirsch and Dr. T. Shioda
for efforts in the initial phases of this work and to Drs. J. Avruch
and D. Weaver for helpful discussions. We are also grateful to Dr. B. Hirayama, Dr. M. Alexander-Bridges, and Dr. G. R. Crabtree for providing antisera and to Dr. David Lee-Parritz for providing the
duodenal biopsies from monkeys.
 |
FOOTNOTES |
*
This work was supported in part by United States Public
Health Service, NIDDK Grants DK01392 and 5P30 DK40561, NICHD Grant HD31215, and Grant P51RR00168 to the New England Regional Primate Research Center.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF007832
To whom correspondence should be addressed: Pediatric Endocrine
Unit, Massachusetts General Hospital, Boston, MA 02114-02696. Tel.:
617-724-2707; Fax: 617-726-3044; E-mail:
rhoads{at}helix.mgh.harvard.edu.
1
The abbreviations used are: SGLT,
Na+/glucose cotransporter; GLUT, facilitated glucose
transporter; EMSA, electrophoretic mobility shift assays; MLTF, major
late transcription factor; USF, upstream stimulatory factor, HNF,
hepatocyte nuclear factor; DCoH, dimerization cofactor of HNF-1; nt,
nucleotide(s); bp, base pair(s); kb, kilobase pair(s); NF1, nuclear
factor 1.
 |
REFERENCES |
-
Hediger, M. A.,
and Rhoads, D. B.
(1994)
Physiol. Rev.
74,
993-1026[Free Full Text]
-
Crane, R. K.,
Miller, D.,
and Bihler, I.
(1961)
in
Membrane Transport and Metabolism (Kleinzeller, A., and Kotyk, A., eds), pp. 439-449, Czechoslovakian Academy of Sciences, Prague
-
Fukumoto, H.,
Seino, S.,
Imura, H.,
Seino, Y.,
Eddy, R. L.,
Fukushima, Y.,
Byers, M. B.,
Shows, T. B.,
and Bell, G. I.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
5434-5438[Abstract/Free Full Text]
-
Davidson, N. O.,
Hausman, A. M. L.,
Ifkowits, C. A.,
Buse, J. B.,
Gould, G. W.,
Burant, C. F.,
and Bell, G. I.
(1992)
Am. J. Physiol.
262,
C795-C800[Abstract/Free Full Text]
-
Thorens, B.,
Flier, J. S.,
Lodish, H. F.,
and Kahn, B. B.
(1990)
Diabetes
39,
712-719[Abstract]
-
Thorens, B.,
Lodish, H. F.,
and Brown, D.
(1990)
Am. J. Physiol.
259,
C286-C294
-
Kayano, T.,
Burant, C. F.,
Fukumoto, H.,
Gould, G. W.,
Fan, Y.-S.,
Eddy, R. L.,
Byers, M. G.,
Shows, T. B.,
Seino, S.,
and Bell, G. I.
(1990)
J. Biol. Chem.
265,
13276-13282[Abstract/Free Full Text]
-
Fisher, R. B.,
and Gardner, M. L. G.
(1976)
J. Physiol.
254,
821-825[Abstract/Free Full Text]
-
Stevenson, N. R.,
Ferrigni, R.,
Parnicky, K.,
Day, S.,
and Fierstein, J. S.
(1975)
Biochim. Biophys. Acta
406,
131-145[Medline]
[Order article via Infotrieve]
-
Stevenson, N. R.,
and Fierstein, J. S.
(1976)
Am. J. Physiol.
230,
731-735
-
Siegel, P. S.
(1961)
J. Comp. Physiol. Psychol.
54,
294-301[CrossRef]
-
Saito, M.,
Murakami, E.,
Nishida, T.,
Fujisawa, Y.,
and Suda, M.
(1976)
J. Biochem. (Tokyo)
80,
563-568[Abstract/Free Full Text]
-
Corpe, C. P.,
and Burant, C. F.
(1996)
Am. J. Physiol.
271,
G211-G216[Abstract/Free Full Text]
-
Ferraris, R. P.,
Villenas, S. A.,
and Diamond, J. M.
(1992)
Am. J. Physiol.
262,
G1060-G1068[Abstract/Free Full Text]
-
Ferraris, R. P.,
Villenas, S. A.,
and Diamond, J. M.
(1992)
Am. J. Physiol.
262,
G1069-G1073[Abstract/Free Full Text]
-
Ferraris, R. P.,
Villenas, S. A.,
and Diamond, J.
(1992)
Am. J. Physiol.
262,
G1047-G1059[Abstract/Free Full Text]
-
Ferraris, R. P.,
and Diamond, J. M.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
5868-5872[Abstract/Free Full Text]
-
Miyamoto, K.-i.,
Hase, K.,
Takagi, T.,
Fujii, T.,
Taketani, Y.,
Minami, H.,
Oka, T.,
and Nakabou, Y.
(1993)
Biochem. J.
295,
211-215
-
Karasov, W. H.,
and Diamond, J. M.
(1987)
in
Physiology of the Gastrointestinal Tract (Johnson, L. R., ed), Vol. 2, pp. 1489-1497, Raven Press, New York
-
Burant, C. F.,
Flink, S.,
DePaoli, A. M.,
Chen, J.,
Lee, W.-S.,
Hediger, M. A.,
Buse, J. B.,
and Chang, E. B.
(1994)
J. Clin. Invest.
93,
578-585
-
Lee, W.-S.,
Kanai, Y.,
Wells, R. G.,
and Hediger, M. A.
(1994)
J. Biol. Chem.
269,
12032-12039[Abstract/Free Full Text]
-
Hediger, M. A.,
Turk, E.,
and Wright, E. M.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
5748-5752[Abstract/Free Full Text]
-
Thorens, B.,
Sarkar, H. K.,
Kaback, H. R.,
and Lodish, H. F.
(1988)
Cell
55,
281-290[CrossRef][Medline]
[Order article via Infotrieve]
-
Rand, E. B.,
DePaoli, A. M.,
Davidson, N. O.,
Bell, G. I.,
and Burant, C. F.
(1993)
Am. J. Physiol.
264,
G1169-G1176[Abstract/Free Full Text]
-
Traber, P. G.
(1990)
Biochem. Biophys. Res. Commun.
173,
765-773[CrossRef][Medline]
[Order article via Infotrieve]
-
Thompson, K. S.,
and Towle, H. C.
(1991)
J. Biol. Chem.
266,
8679-8682[Abstract/Free Full Text]
-
Cathala, G.,
Savouret, J.-F.,
Mendez, B.,
West, B. L.,
Karin, M.,
Martial, J. A.,
and Baxter, J. D.
(1983)
DNA (N. Y.)
2,
329-335[Medline]
[Order article via Infotrieve]
-
Hirayama, B. A.,
Wong, H. C.,
Smith, C. D.,
Hagenbuch, B. A.,
Hediger, M. A.,
and Wright, E. M.
(1991)
Am. J. Physiol.
261,
C296-C304[Abstract/Free Full Text]
-
Flint, N.,
Cove, F. L.,
and Evans, G. S.
(1991)
Biochem. J.
280,
331-334
-
Greenberg, M. E.
(1990)
in
Current Protocols in Molecular Biology (Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K., eds), pp. 4.10.1-4.10.9, John Wiley & Sons, New York
-
Dignam, J. D.,
Lebovitz, R. M.,
and Roeder, R. G.
(1983)
Nucleic Acids Res.
11,
1475-1489[Abstract/Free Full Text]
-
Bernards, R.
(1991)
EMBO J.
10,
1119-1125[Medline]
[Order article via Infotrieve]
-
Courtois, G.,
Morgan, J. G.,
Campbell, L. A.,
Fourel, G.,
and Crabtree, G. R.
(1987)
Science
238,
688-692[Abstract/Free Full Text]
-
Weiser, M. M.
(1973)
J. Biol. Chem.
248,
2536-2541[Abstract/Free Full Text]
-
Turk, E.,
Martín, M. G.,
and Wright, E. M.
(1994)
J. Biol. Chem.
269,
15204-15209[Abstract/Free Full Text]
-
Ghosh, D.
(1990)
Nuceic Acids Res.
18,
1749-1756[Abstract/Free Full Text]
-
Vaulont, S.,
Puzenat, N.,
Levrat, F.,
Cognet, M.,
Kahn, A.,
and Raymondjean, M.
(1989)
J. Mol. Biol.
209,
205-219[CrossRef][Medline]
[Order article via Infotrieve]
-
Ogier, H.,
Munnich, A.,
Lyonnet, S.,
Vaulont, S.,
Reach, G.,
and Kahn, A.
(1987)
Eur. J. Biochem.
166,
365-370[Medline]
[Order article via Infotrieve]
-
Mendel, D. B.,
and Crabtree, G. R.
(1991)
J. Biol. Chem.
266,
677-680[Free Full Text]
-
Gehring, W. J.,
Affolter, M.,
and Burglin, T.
(1994)
Annu. Rev. Biochem.
63,
487-526[CrossRef][Medline]
[Order article via Infotrieve]
-
Mendel, D. B.,
Hansen, L. P.,
Graves, M. K.,
Conley, P. B.,
and Crabtree, G. R.
(1991)
Genes Dev.
5,
1042-1056[Abstract/Free Full Text]
-
Mendel, D. B.,
Khavari, P. A.,
Conley, P. B.,
Graves, M. K.,
Hansen, L. P.,
Admon, A.,
and Crabtree, G. R.
(1991)
Science
254,
1762-1767[Abstract/Free Full Text]
-
Wu, G. D.,
Chen, L.,
Forslund, K.,
and Traber, P. G.
(1994)
J. Biol. Chem.
269,
17080-17085[Abstract/Free Full Text]
-
Ahn, Y.-h.,
Kim, J.-w.,
Han, G.-s.,
Lee, B.-g.,
and Kim, Y.-s.
(1995)
Arch. Biochem. Biophys.
323,
387-396[CrossRef][Medline]
[Order article via Infotrieve]
-
Mahraoui, L.,
Takeda, J.,
Mesonero, J.,
Chantret, I.,
Dussaulx, E.,
Bell, G. I.,
and Brot-Laroche, E.
(1994)
Biochem, J.
301,
169-175
-
Lee, Y.-H.,
Alberta, J. A.,
Gonzalez, F. J.,
and Waxman, D. J.
(1994)
J. Biol. Chem.
269,
14681-14689[Abstract/Free Full Text]
-
Saito, M.,
Suda, M.,
and Matzuda, H.
(1978)
Am. J. Physiol.
234,
E500-E503
-
Yamagata, K.,
Oda, N.,
Kaisaki, P. J.,
Menzel, S.,
Furuta, H.,
Vaxillaire, M.,
Southam, L.,
Cox, R. D.,
Lathrop, G. M.,
Boriraj, V. V.,
Chen, X.,
Cox, N. J.,
Oda, Y.,
Yano, H.,
Le Beau, M. M.,
Yamada, S.,
Nishigori, H.,
Takeda, J.,
Fajans, S. S.,
Hattersley, A. T.,
Iwasaki, N.,
Hansen, T.,
Pedersen, O.,
Polonsky, K. S.,
Turner, R. C.,
Velho, G.,
Chevre, J.-C.,
Froguel, P.,
and Bell, G. I.
(1996)
Nature
384,
455-458[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. F. Keaney Jr and D. R. Weaver
Vascular Rhythms and Adaptation: Do Your Arteries Know What Time It Is?
Circulation,
March 24, 2009;
119(11):
1463 - 1466.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kekuda, P. Saha, and U. Sundaram
Role of Sp1 and HNF1 transcription factors in SGLT1 regulation during chronic intestinal inflammation
Am J Physiol Gastrointest Liver Physiol,
June 1, 2008;
294(6):
G1354 - G1361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T. Stearns, A. Balakrishnan, J. Rounds, D. B. Rhoads, S. W. Ashley, and A. Tavakkolizadeh
Capsaicin-sensitive vagal afferents modulate posttranscriptional regulation of the rat Na+/glucose cotransporter SGLT1
Am J Physiol Gastrointest Liver Physiol,
April 1, 2008;
294(4):
G1078 - G1083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Freitas, G. F. Anhe, K. F. S. Melo, M. M. Okamoto, M. Oliveira-Souza, S. Bordin, and U. F. Machado
Na+-Glucose Transporter-2 Messenger Ribonucleic Acid Expression in Kidney of Diabetic Rats Correlates with Glycemic Levels: Involvement of Hepatocyte Nuclear Factor-1{alpha} Expression and Activity
Endocrinology,
February 1, 2008;
149(2):
717 - 724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bosse, J. J. Fialkovich, C. M. Piaseckyj, E. Beuling, H. Broekman, R. J. Grand, R. K. Montgomery, and S. D. Krasinski
Gata4 and Hnf1{alpha} are partially required for the expression of specific intestinal genes during development
Am J Physiol Gastrointest Liver Physiol,
May 1, 2007;
292(5):
G1302 - G1314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Veyhl, T. Keller, V. Gorboulev, A. Vernaleken, and H. Koepsell
RS1 (RSC1A1) regulates the exocytotic pathway of Na+-D-glucose cotransporter SGLT1
Am J Physiol Renal Physiol,
December 1, 2006;
291(6):
F1213 - F1223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bosse, H. M. van Wering, M. Gielen, L. N. Dowling, J. J. Fialkovich, C. M. Piaseckyj, F. J. Gonzalez, T. E. Akiyama, R. K. Montgomery, R. J. Grand, et al.
Hepatocyte nuclear factor-1{alpha} is required for expression but dispensable for histone acetylation of the lactase-phlorizin hydrolase gene in vivo
Am J Physiol Gastrointest Liver Physiol,
May 1, 2006;
290(5):
G1016 - G1024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Osswald, K. Baumgarten, F. Stumpel, V. Gorboulev, M. Akimjanova, K.-P. Knobeloch, I. Horak, R. Kluge, H.-G. Joost, and H. Koepsell
Mice without the Regulator Gene Rsc1A1 Exhibit Increased Na+-D-Glucose Cotransport in Small Intestine and Develop Obesity
Mol. Cell. Biol.,
January 1, 2005;
25(1):
78 - 87.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wang, A. Klopot, J.-N. Freund, L. N. Dowling, S. D. Krasinski, and J. C. Fleet
Control of differentiation-induced calbindin-D9k gene expression in Caco-2 cells by cdx-2 and HNF-1{alpha}
Am J Physiol Gastrointest Liver Physiol,
November 1, 2004;
287(5):
G943 - G953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. van Wering, T. Bosse, A. Musters, E. de Jong, N. de Jong, C. E. Hogen Esch, F. Boudreau, G. P. Swain, L. N. Dowling, R. K. Montgomery, et al.
Complex regulation of the lactase-phlorizin hydrolase promoter by GATA-4
Am J Physiol Gastrointest Liver Physiol,
October 1, 2004;
287(4):
G899 - G909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Pan, T. Terada, M. Okuda, and K.-I. Inui
The Diurnal Rhythm of the Intestinal Transporters SGLT1 and PEPT1 Is Regulated by the Feeding Conditions in Rats
J. Nutr.,
September 1, 2004;
134(9):
2211 - 2215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wang, C. Coffinier, M. K. Thomas, L. Gresh, G. Eddu, T. Manor, L. L. Levitsky, M. Yaniv, and D. B. Rhoads
Selective Deletion of the Hnf1{beta} (MODY5) Gene in {beta}-Cells Leads to Altered Gene Expression and Defective Insulin Release
Endocrinology,
August 1, 2004;
145(8):
3941 - 3949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ramsanahie, M. S. Duxbury, T. C. Grikscheit, A. Perez, D. B. Rhoads, J. Gardner-Thorpe, J. Ogilvie, S. W. Ashley, J. P. Vacanti, and E. E. Whang
Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine
Am J Physiol Gastrointest Liver Physiol,
December 1, 2003;
285(6):
G1345 - G1352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Pan, T. Terada, M. Okuda, and K.-I. Inui
Altered Diurnal Rhythm of Intestinal Peptide Transporter by Fasting and Its Effects on the Pharmacokinetics of Ceftibuten
J. Pharmacol. Exp. Ther.,
November 1, 2003;
307(2):
626 - 632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Kles and K. A. Tappenden
Hypoxia differentially regulates nutrient transport in rat jejunum regardless of luminal nutrient present
Am J Physiol Gastrointest Liver Physiol,
December 1, 2002;
283(6):
G1336 - G1342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Boudreau, E. H. H. M. Rings, H. M. van Wering, R. K. Kim, G. P. Swain, S. D. Krasinski, J. Moffett, R. J. Grand, E. R. Suh, and P. G. Traber
Hepatocyte Nuclear Factor-1alpha , GATA-4, and Caudal Related Homeodomain Protein Cdx2 Interact Functionally to Modulate Intestinal Gene Transcription. IMPLICATION FOR THE DEVELOPMENTAL REGULATION OF THE SUCRASE-ISOMALTASE GENE
J. Biol. Chem.,
August 23, 2002;
277(35):
31909 - 31917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Pan, T. Terada, M. Irie, H. Saito, and K.-I. Inui
Diurnal rhythm of H+-peptide cotransporter in rat small intestine
Am J Physiol Gastrointest Liver Physiol,
July 1, 2002;
283(1):
G57 - G64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Steyermark, M. M. Lam, and J. Diamond
Quantitative evolutionary design of nutrient processing: Glucose
PNAS,
June 25, 2002;
99(13):
8754 - 8759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Jiang, E. S. David, N. Espina, and R. P. Ferraris
GLUT-5 expression in neonatal rats: crypt-villus location and age-dependent regulation
Am J Physiol Gastrointest Liver Physiol,
September 1, 2001;
281(3):
G666 - G674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tavakkolizadeh, U. V. Berger, K. R. Shen, L. L. Levitsky, M. J. Zinner, M. A. Hediger, S. W. Ashley, E. E. Whang, and D. B. Rhoads
Diurnal rhythmicity in intestinal SGLT-1 function, Vmax, and mRNA expression topography
Am J Physiol Gastrointest Liver Physiol,
February 1, 2001;
280(2):
G209 - G215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Jiang and R. P. Ferraris
Developmental reprogramming of rat GLUT-5 requires de novo mRNA and protein synthesis
Am J Physiol Gastrointest Liver Physiol,
January 1, 2001;
280(1):
G113 - G120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Yang, Y. Tian, J. Wada, N. Kashihara, E. Wallner, D. Peterson, and Y. S. Kanwar
Expression characteristics and relevance of sodium glucose cotransporter-1 in mammalian renal tubulogenesis
Am J Physiol Renal Physiol,
October 1, 2000;
279(4):
F765 - F777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ishii, A. J. Hansen, and P. I. Mackenzie
Octamer Transcription Factor-1 Enhances Hepatic Nuclear Factor-1alpha -Mediated Activation of the Human UDP Glucuronosyltransferase 2B7 Promoter
Mol. Pharmacol.,
May 1, 2000;
57(5):
940 - 947.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. G. Martin, J. Wang, R. S. Solorzano-Vargas, J. T. Lam, E. Turk, and E. M. Wright
Regulation of the human Na+-glucose cotransporter gene, SGLT1, by HNF-1 and Sp1
Am J Physiol Gastrointest Liver Physiol,
April 1, 2000;
278(4):
G591 - G603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Scheving and W.-H. Jin
Circadian regulation of uroguanylin and guanylin in the rat intestine
Am J Physiol Cell Physiol,
December 1, 1999;
277(6):
C1177 - C1183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Korn, T. Kuhlkamp, C. Track, I. Schatz, K. Baumgarten, V. Gorboulev, and H. Koepsell
The Plasma Membrane-associated Protein RS1 Decreases Transcription of the Transporter SGLT1 in Confluent LLC-PK1 Cells
J. Biol. Chem.,
November 21, 2001;
276(48):
45330 - 45340.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|